LINC00941 and leukocyte adhesion deficiency: LINC00941 expression has been used to successfully predict the survival of patients with lung adenocarcinoma (LAD) (79, 80) and was identified as a biomarker for hypoxia, which is associated with reduced survival of LAD patients (81, 82).